glutathione s-transferase uniprot Information on EC 2.5.1.18 - transferase and Organism(s) Homo sapiens and Accession O15217 Glutathione R Glutathione Transferase P1-1 an Enzyme

doi:10.1186/s12905-020-00930-w

In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress

Imai and Guarente, 2014), an aspect that could worsen in these diseases because of its progressive nature ( + levels have been shown to decrease with age, leading to low levels in the brain (Zhu et al., 2015)

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited published safety data Reported well-tolerated in small Russian studies Known interactions GABAergic medications (theoretical unstudied) Benzodiazepines (theoretical additive sedation) Contraindications Pregnancy/lactation (unstudied) Hypersensitivity REGULATORY STATUS FDA Not FDA-approved

Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation